Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Latvia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Latvia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20031
20052
20062
20071
20081
20092
20104
20112
20124
20132
20141
20162
20172
20183
20191
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated7
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Sanofi6
Novo Nordisk A/S5
AstraZeneca4
Lexicon Pharmaceuticals3
Boehringer Ingelheim2
GlaxoSmithKline2
Janssen Research & Development, LLC2
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 235
Diabetes Mellitus8
Cardiovascular Diseases4
Glucose Intolerance3
Glucose Metabolism Disorders3
Dyslipidemias2
Heart Failure2
Hyperglycemia2
Renal Insufficiency2
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.